[Opinion] Should the 90% CI for GMR be required to encompass 1 [RSABE / ABEL]

posted by jag009  – NJ, 2018-03-29 21:22 (1594 d 00:22 ago) – Posting: # 18621
Views: 8,836

If I recall (or I am imagining things), FDA published a paper about NTI drug BE assessment (Helmut, help! Am I hallucinating again?)

Anyhow, Have you looked at this FDA slide presentation before?



Complete thread:

UA Flag
 Admin contact
22,289 posts in 4,666 threads, 1,585 registered users;
online 17 (0 registered, 17 guests [including 6 identified bots]).
Forum time: Tuesday 21:44 CEST (Europe/Vienna)

The existing scientific concepts cover always only
a very limited part of reality,
and the other part that has not yet
been understood is infinite.    Werner Heisenberg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz